Recently, the Ahren team published a blog outlining some of the therapeutic routes and testing methods to tackle Covid-19.
We are researching this space carefully, looking to identify high calibre groups that have potential to deliver material impact in the current crisis. We are particularly keen to support novel therapeutics that the big pharma companies are unlikely to work on. In addition, the need for mass serological testing (antibody tests) is urgent and opportunities within this category are of particular interest.
We would look at:
- Small molecule antivirals
- Antibody based antivirals
- Therapies using convalescent plasma
- Side effect management e.g. anti IL-6 treatments
- Viral RNA tests
- Antibody tests
If you are working on one of the above areas, or another, please get in touch at firstname.lastname@example.org.
This document and the information contained herein is for information purposes only. The document is provided on a non-reliance basis contains forward looking statements and opinions of the manager, which may be subject to change or revision without notice. Some information contained herein was based on, obtained or derived from data published or prepared by other parties (“Third-Party Information”).
None of Ahren or its affiliates, directors, officers, employees, partners, shareholders or agents (each, an “Ahren Party”) assumes any responsibility for the accuracy of the document or any Third-Party Information. No Ahren Party makes any representation or warranty, express or implied, as to the accuracy or completeness of this document or any Third-Party Information and no Ahren Party shall have any liability to the recipient or any other person relating to or resulting from the use of or reliance on any such information contained herein or any errors therein or omissions therefrom. No warranty, express or implied, or assurance is given by the manager or any of its directors, officers, members or employees.
Nothing contained in this document may be relied upon as a guarantee, promise, assurance or a representation as to the future. Except as otherwise indicated, the information provided in this Investor Letter is based on matters as they exist as of the date listed on the cover and not as of any future date, and will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing or changes occurring after the date hereof. The views expressed in this Investor Letter are subject to change based on market and other conditions. In considering the performance information contained herein, prospective investors should bear in mind that past, forecasted or targeted performance is not necessarily indicative of future results, and there can be no assurance that comparable results will be achieved.
Neither Ahren nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the information contained herein, and nothing contained herein should be relied upon as a promise or representation as to past or future performance of Ahren or the fund or any other entity.
The recipient acknowledges that, to the maximum extent permitted by law, each of Ahren and its related parties or affiliates disclaims all liability to the recipient or to any other person for any expense, cost, loss or damage of any kind including direct, indirect or consequential loss or damage (however caused, including by negligence) incurred by any person arising from or relating to any information included or omitted from this Investor Letter, whether by reason of such information being inaccurate or incomplete or for any other reason. This Investor Letter does not constitute and should not be considered as any form of financial opinion or recommendation. The recipient should conduct its own inquiries as to the adequacy, accuracy, completeness and reliability of any information, whether such information is contained in this Investor Letter or not, relating to Ahren or the fund.
No action should be taken by any recipient which, in the light of the information herein, would render such action illegal or violate any applicable laws or regulations. Neither the manager nor any of its directors, officers, members or employees accepts any liability whatsoever for its accuracy or any action taken by a recipient which is illegal or in violation of any applicable law or regulation as a result of receiving this document and its contents.
The Site cannot and does not contain medical or health related advice. The medical or health information is provided for general informational and educational purposes only and is not a substitute for professional advice. Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of medical or health advice.
The Site does not offer, and should not be construed in any way as offering legal, regulatory or tax advice. The information is provided for general informational purposes only and is not a substitute for professional legal or tax advice.
THE USE OR RELIANCE OF ANY INFORMATION CONTAINED ON THIS SITE IS SOLELY AT YOUR OWN RISK.